GENEART AG Publishes Consolidated Financial Statements 2008.

(From Hugin)

- Consolidated net sales increase by 27.5 % to EUR 15.7M in 2008 - EBIT reaches EUR 0.8M after EUR 1.8M in the previous year - Operating cash flow increases to EUR 2.8M (previous year: EUR -0.9M) - Expectations for current fiscal year 2009: GENEART assumes at least constant net sales despite uncertain market environment

Regensburg, April 30, 2009 - GENEART AG, global leader in gene synthesis and specialist in the field of Synthetic Biology, confirms its preliminary numbers for 2008 published in March. Net sales increased by 27.5 % over the previous year to EUR 15.7M. EBIT reached EUR 0.8M after EUR 1.8M in the previous year. GENEART shows earnings before taxes (EBT) of EUR 1.1M, compared to EUR 2.2M in 2007. The operating cash flow increased to …